AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Johns Hopkins University at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Johns Hopkins University brings 2 presentations to AMP 2026 in Seattle. Its program covers practical approaches to putting long-read sequencing to work in the clinic and the use of menin inhibitors in acute myeloid leukaemia.
| Organization | AMP 2026 Attendance |
|---|---|
Johns Hopkins University Baltimore, MD | |
Private research university in Baltimore with medical school work on cancer genetics, cell-free DNA and molecular diagnostics. | Talk Fri, Nov 13 1:15pm–2:00pm Menin Inhibitor Use in Acute Myeloid Leukemia Current evidence for menin inhibition in acute myeloid leukemia, approved and investigational drugs, and residual disease monitoring. Talk Sat, Nov 14 3:00pm–3:30pm Putting Long-Read Sequencing to Work: Practical Approaches for the Clinic Practical long-read sequencing for structural variants across large cohorts, targeted enrichment and difficult clinical samples. |
Find decision makers at Johns Hopkins University
Tell us what you sell and we’ll find the people at Johns Hopkins University most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction